RT Conference Proceedings
T1 NICE-NEC, a phase II study of platinum-doublet chemotherapy in combination with nivolumab as first-line treatment in subjects with unresectable, locally advanced or metastatic grade 3 neuroendocrine neoplasms (NENs) of the gastroenteropancreatic tract or of unknown origin. GETNE-T1913
A1 Riesco Martinez, M. C.
A1 Capdevila, J.
A1 Alonso, V.
A1 Teule, A.
A1 Grande, E.
A1 Jimenez-Fonseca, P.
A1 Benavent, M.
A1 Alonso Gordoa, T.
A1 Custodio, A.
A1 Hierro Carbo, C.
A1 Lopez, C.
A1 Sevilla Garcia, I.
A1 Garcia-Carbonero, R.
PB Elsevier
SN 0923-7534
YR 2020
FD 2020-09-01
LK https://hdl.handle.net/10668/26986
UL https://hdl.handle.net/10668/26986
LA en
DS RISalud
RD Apr 8, 2025